Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2005
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/15/2005CN1206220C Process for producing 2-(4-pyridyl) ethanethiol
06/15/2005CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient
06/14/2005US6906195 Heat resistance, colorfastness
06/14/2005US6906166 Multicolor; light emitting diodes; polyarylenevinylenes
06/14/2005US6906105 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer
06/14/2005US6906104 Aminediols for the treatment of Alzheimer's disease
06/14/2005US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
06/14/2005US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906063 For therapy and prophylaxis of thrombosis in a mammal
06/14/2005US6905455 Radioactive member and method of making
06/14/2005CA2308817C Process for preparing 2-phenyl-3-aminopyridine, substituted phenyl derivatives thereof, and salts thereof
06/14/2005CA2101684C Substituted (hetero)aryl compounds, process for their preparation, agents containing them, and their use as safeners
06/09/2005WO2005051941A1 Thione derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
06/09/2005WO2005051914A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051901A1 Anti-cancer agents
06/09/2005WO2005051892A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines
06/09/2005WO2005051890A1 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40
06/09/2005WO2005051889A1 M-diaminobenzoles and the acidic adducts thereof and use thereof in colouring agents
06/09/2005WO2005051387A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
06/09/2005WO2005051386A1 Hmg-coa reductase inhibitors and method
06/09/2005WO2005051373A1 Receptor function regulating agent
06/09/2005WO2005051317A2 Substituted imidazo ring systems and methods
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
06/09/2005WO2005016505A3 Method for the manufacture of cyanopyridines and catalysts suitable therefor
06/09/2005WO2003088897A3 Fab i inhibitors
06/09/2005US20050124808 Using nickel or palladium coupling catalyst containing phosphine or phosphite ligands
06/09/2005US20050124807 oxidation of a hetero alcohol in presence od an 2,2,6,6-teraalkylpiperidin-1-oxy comound
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124679 Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors
06/09/2005US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
06/09/2005US20050124625 For example, ((2R,5S)-4-(8-cyano-quinolin-5-yl)-2,5-dimethyl-piperazine-1-carboxylic acid(4-trifluoromethyl-pyridin-3-yl)-amide); use in treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders
06/09/2005US20050124610 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma
06/09/2005US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism
06/09/2005US20050124561 Administering fungicide for mucous membrane; asthma therapy
06/09/2005US20050124209 Illuminated electrical cords and outlets
06/09/2005US20050124069 Transfection reagents
06/09/2005US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/09/2005US20050123475 Preparation and use of alkylating agents
06/09/2005DE10351842A1 m-Diaminobenzole und deren Säureaddukte sowie deren Verwendung in Färbemitteln m-diaminobenzenes and their acid adducts, and their use in colorants
06/09/2005CA2547430A1 Receptor function regulating agent
06/09/2005CA2547281A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines
06/09/2005CA2547020A1 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
06/09/2005CA2546709A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546142A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1538145A1 Process for production of phenoxy-substituted 2-pyridone compounds
06/08/2005EP1537088A2 Substituted pyridines or pyrimidines, method for their production, agents containing said substances and the use thereof as pesticides
06/08/2005EP1537085A1 Oxytocin inhibitors
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1537076A1 Novel vinyl carboxylic acid derivatives and their therapeutical use
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537074A1 Cathepsin cysteine protease inhibitors
06/08/2005EP1537072A1 Substituted aminoethers for the treatment of alzheimer s disease
06/08/2005EP1537068A1 Materials and methods for treating hypercholesterolemia
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1392673B1 1,3-dihydroxybenzene derivatives and colorants containing said compounds
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1057816B1 Method for producing heteroaromatic aldehydes
06/08/2005EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625549A Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
06/08/2005CN1623988A Biaryl sulfonamides and methods for using same
06/08/2005CN1623987A Novel processes for preparing torsemide
06/08/2005CN1623986A Method for preparing synthetic methyl pyridine
06/08/2005CN1623660A Preparation process of load type synthetic methyl pyrdine catalyst
06/08/2005CN1205202C N-carbanilides used as pesticides
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/08/2005CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
06/08/2005CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
06/07/2005US6903220 Synthesis of chiral 2-alkyl amino acids
06/07/2005US6903218 Substituted or unsubstituted aryl-1-hydroxyethylaminocarbonylalkyl-chroman-sulfonamide compounds are useful in the treatment of beta-3 receptor mediated conditions
06/07/2005US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903118 Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/02/2005WO2005049609A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
06/02/2005WO2005049604A2 Antithrombotic aromatic ethers
06/02/2005WO2005049594A1 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049593A2 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
06/02/2005WO2005049574A1 Androgen receptor modulators
06/02/2005WO2005049573A1 Phenyl derivatives as ppar agonists
06/02/2005WO2005049572A1 Benzannelated compounds as ppar activators